All Companies

JNJ

Johnson & Johnson

Pharmaceutical Preparations

$269.99updated Sep 19, 2026

Congressional trading profile for Johnson & Johnson (JNJ), covering 53 disclosed transactions by 21 lawmakers.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Total Trades

53

Politicians Trading

21

Last Traded

Aug 27, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Ro KhannaDSep 4, 2026Aug 7, 2026Sell$1,001 - $15,000+4.15%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+29.61%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+38.28%
Jared MoskowitzDNov 22, 2025Oct 10, 2025Sell$1,001 - $15,000+41.56%
Jared MoskowitzDNov 22, 2025Oct 10, 2025Sell$1,001 - $15,000+41.56%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+52.90%
Kelly MorrisonDSep 11, 2025Aug 19, 2025Sell$1,001 - $15,000+51.85%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+54.53%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+78.84%
Julie JohnsonDMay 14, 2025Apr 1, 2025Sell$1,001 - $15,000+76.18%
Gilbert Ray Cisneros, Jr.DMay 6, 2025Apr 29, 2025Sell$1,001 - $15,000+73.17%
George WhitesidesDApr 23, 2025Mar 24, 2025Sell$100,001 - $250,000+65.34%
Josh GottheimerDApr 10, 2025Mar 7, 2025Sell$1,001 - $15,000+61.97%
Gilbert Ray Cisneros, Jr.DFeb 11, 2025Jan 24, 2025Sell$1,001 - $15,000+83.89%